GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » Accounts Receivable

Tasly Pharmaceutical Group Co (SHSE:600535) Accounts Receivable : ¥971 Mil (As of Mar. 2025)


View and export this data going back to 2002. Start your Free Trial

What is Tasly Pharmaceutical Group Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Tasly Pharmaceutical Group Co's accounts receivables for the quarter that ended in Mar. 2025 was ¥971 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Tasly Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 was 43.12.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Tasly Pharmaceutical Group Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ¥0.93.


Tasly Pharmaceutical Group Co Accounts Receivable Historical Data

The historical data trend for Tasly Pharmaceutical Group Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tasly Pharmaceutical Group Co Accounts Receivable Chart

Tasly Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,872.21 1,294.63 896.21 688.00 780.14

Tasly Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 836.13 868.39 1,040.70 780.14 970.95

Tasly Pharmaceutical Group Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Tasly Pharmaceutical Group Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Tasly Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=970.95/2054.886*91
=43.12

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Tasly Pharmaceutical Group Co's accounts receivable are only considered to be worth 75% of book value:

Tasly Pharmaceutical Group Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2930.042+0.75 * 970.95+0.5 * 1616.305-2850.779
-0-225.991)/1493.950
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Tasly Pharmaceutical Group Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Tasly Pharmaceutical Group Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tasly Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410
Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.
Executives
Wu Nai Feng Director

Tasly Pharmaceutical Group Co Headlines

No Headlines